AAAS Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HeLa cervical adenocarcinoma line, featuring targeted disruption of the AAAS gene locus. This polyclonal format provides a heterogeneous population with diverse genetic edits, enabling robust functional analyses of aladin, the nucleoporin encoded by AAAS. The knockout model serves as a versatile platform to dissect aladin-dependent mechanisms in a human epithelial cancer background, supporting both cellular and molecular studies.
The HeLa host cell line is an immortalized epithelial model established from a cervical adenocarcinoma, positive for HPV18, and exhibits stable epithelial morphology. HeLa cells are extensively characterized and widely employed in cancer biology, signal transduction, and nuclear transport research. Their rapid growth and well-defined genetic landscape facilitate gene-editing applications, and the epithelial context is particularly relevant for investigating nuclear pore complex (NPC) function and its crosstalk with cell architecture.
Aladin acts as a scaffolding nucleoporin that anchors the cytoplasmic face of the NPC to the nuclear envelope through direct interaction with NDC1. It is essential for NPC assembly and facilitates both protein import and mRNA export. Transcriptional regulation by SP1 and cell cycle factors modulates AAAS expression, while aladin??s function is coupled to the Ran GTPase cycle and interactions with nucleoporins such as NUP62, NUP107, and NUP160. Disruption of aladin impairs the NUP107-160 subcomplex anchorage and compromises large-cargo transport, thereby affecting cellular homeostasis.
In HeLa cells, loss of aladin disrupts NPC architecture and nucleocytoplasmic trafficking, potentially impacting gene expression and cell cycle progression. This model is particularly relevant for studying triple A syndrome caused by AAAS mutations and for exploring the role of nuclear transport defects in neurodegenerative diseases such as hereditary spastic paraplegia, Alzheimer??s disease, and amyotrophic lateral sclerosis. The HeLa background provides a controlled system to evaluate how aladin deficiency influences cancer cell biology and stress responses.
Researchers can utilize this knockout population for immunofluorescence localization of NPC components, western blot analysis of aladin and interacting partners, and fluorescent reporter-based nuclear import/export assays. Co-immunoprecipitation experiments with NDC1 or NUP62 help map protein interactions, while RT-qPCR profiling of downstream transport targets reveals compensatory mechanisms. Additional methods such as electron microscopy for NPC ultrastructure and flow cytometry for nuclear envelope integrity further enhance the model??s utility. For further technical information, please contact Ascent Research.
